Top Menu

Market Research
Search India Import/Export data to understand your markets and monitor your competition.

20+ Country Market Analysis Report

Export Import Market Report

demo

Find Sales Prospects
Instantly generate lists of potential customers based on trade activity.

Find Sales Prospects

Instantly generate lists of potential customers based on trade activity.

Request Sample Data

Evaluate Suppliers
Search for new suppliers, monitor existing ones and keep track of trends.

Access the world's largest and most comprehensive database of International trade. Whether you are looking to generate leads locally or expand your business globally, TRADE GENIUS has what your business needs.

SL2
DATA FROM 30+ COUNTRIES
Import and Export data from Globally, USA, UK, RUSSIA, and CHINA
SL2
Market Analysis Report
Based on Global Import Export Data
SL2
60,000,000+ SHIPMENTS
Records include product details, FOB values, HTS codes, and much more.
demo
Monitor Competitors
Tailor a solution specific to your industry, with deep expertise in Chemicals, Transportation, and more.
contact

Mail us: info@tradegeniusindia.com

In The Third Quarter Of FY2017 Indian Pharma Exports Show An Increase

DRUGS REUTERSDuring the October-December quarters of 2016, The exports of Indian pharma sector increased by 5.6% when compared with the exports during the same period last year. As per Pharmaceuticals Export Promotion Council (Pharmexcil), this data was reported.

During the second half of this fiscal, there is a rise in exports forecasted by Pharmexcil. There has been seen a rise of 9.7% for the pharma exports of India and in the last fiscal reached to $16.89 billion. The present quarter of January to ¬March from that of October-¬December 2016, will take the export growth even higher for the pharma body.

At the US Food and Drug Administration (USFDA), from India, about 700 drug manufacturing units are registered. In 2016, At least 30% of the USFDA granted abbreviated new drug applications from India. Hence, in the next fiscal, it shows that the generic exports are going to rise.

In 2015, The Indian pharma companies were granted 388 ANDAs and in 2016386 ANDAs till the month of November. To the markets of US and Europe, about 50% of the drugs produced in India are being shipped which have very high standards of regulation.

The pharma exports are stable, in terms of volume. The pharma exports have fallen by 1.96% in terms of value and during April¬-October in FY 2016-17 reached to $ 9,848.2 million from the value in the same period of FY 2015-16.

From September 2015, the US has been controlling the prices of generics which can have an impact on the Indian Pharma industry. By more export volume this fall in value can be balanced.

Hello. Add your message here.